1. The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial. (January 2021) Authors: Gilleen, James; Nottage, Judith; Yakub, Farah; Kerins, Sarah; Valdearenas, Lorena; Uz, Tolga; Lahu, Gez; Tsai, Max; Ogrinc, Frank; Williams, Steve C; Ffytche, Dominic; Mehta, Mitul A; Shergill, Sukhi S Journal: Journal of psychopharmacology Issue: Volume 35:Number 1(2021) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗